Literature DB >> 9246212

IL-10 production and CD40L expression in patients with common variable immunodeficiency.

A Oliva1, E Scala, I Quinti, R Paganelli, I J Ansotegui, A Giovannetti, M Pierdominici, F Aiuti, F Pandolfi.   

Abstract

The authors studied CD40 ligant (CD40L) expression and interleukin-10 (IL-10) production in 16 patients with common variable immunodeficiency (CVI). Mean CD40L expression, determined by using cytofluorimetry, and measured as the mean fluorescence intensity following stimulation of peripheral blood mononuclear cells (PBMC) with phorbol myristate acetate (PMA) and calcium ionophore in 12 patients, was comparable to that of controls. However, three CVI patients showed fluorescence intensity in stimulated cells below 2 standard deviations of normal donors' mean and two other patients had only a slight increase of stimulated versus unstimulated cells (< 10 channels). IL-10 production after stimulation of PBMC with both anti-CD3 or anti-CD3 plus PMA gave similar results in CVI patients and normal controls. In vitro stimulation of PBMC with anti-CD40 and various combinations of cytokines (IL-2, IL-4 and IL-10) induced IgG production above 100 ng/ml in one CVI patient out of 13 tested. The data suggest that alterations of IL-10 production are unlikely to play a major role in the pathogenesis of impaired IgG production in most CVI patients. CD40L appears to be normally expressed in two thirds of CVI patients, but it may be functionally defective.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9246212     DOI: 10.1046/j.1365-3083.1997.d01-95.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  8 in total

1.  International Consensus Document (ICON): Common Variable Immunodeficiency Disorders.

Authors:  Francisco A Bonilla; Isil Barlan; Helen Chapel; Beatriz T Costa-Carvalho; Charlotte Cunningham-Rundles; M Teresa de la Morena; Francisco J Espinosa-Rosales; Lennart Hammarström; Shigeaki Nonoyama; Isabella Quinti; John M Routes; Mimi L K Tang; Klaus Warnatz
Journal:  J Allergy Clin Immunol Pract       Date:  2015-11-07

2.  B-cell and T-cell phenotypes in CVID patients correlate with the clinical phenotype of the disease.

Authors:  Gaël Mouillot; Maryvonnick Carmagnat; Laurence Gérard; Jean-Luc Garnier; Claire Fieschi; Nicolas Vince; Lionel Karlin; Jean-François Viallard; Roland Jaussaud; Julien Boileau; Jean Donadieu; Martine Gardembas; Nicolas Schleinitz; Felipe Suarez; Eric Hachulla; Karen Delavigne; Martine Morisset; Serge Jacquot; Nicolas Just; Lionel Galicier; Dominique Charron; Patrice Debré; Eric Oksenhendler; Claire Rabian
Journal:  J Clin Immunol       Date:  2010-05-01       Impact factor: 8.317

3.  Successful immunosuppressive therapy with cyclosporine A for posthepatitis B-cell deficiency with activated cytoplasmic interferon--gamma-positive T-lymphocytes.

Authors:  Hiroko Otsubo; Ken Kaito; Yoji Ogasawara; Takaki Shimada; Noriko Usui; Masayuki Kobayashi
Journal:  Int J Hematol       Date:  2002-04       Impact factor: 2.490

4.  T-cell response to viral antigens in adults and children with common variable immunodeficiency and specific antibody deficiency.

Authors:  L M Haveman; J Scherrenburg; L J Maarschalk-Ellerbroek; P D Hoek; R Schuurman; W de Jager; P M Ellerbroek; B J Prakken; D van Baarle; J M van Montfrans
Journal:  Clin Exp Immunol       Date:  2010-04-09       Impact factor: 4.330

5.  Three novel mutations reflect the variety of defects causing phenotypically diverse X-linked hyper-IgM syndrome.

Authors:  E López-Granados; R Cambronero; A Ferreira; G Fontán; M C García-Rodríguez
Journal:  Clin Exp Immunol       Date:  2003-07       Impact factor: 4.330

Review 6.  Cytokines in common variable immunodeficiency as signs of immune dysregulation and potential therapeutic targets - a review of the current knowledge.

Authors:  Farnaz Najmi Varzaneh; Bärbel Keller; Susanne Unger; Asghar Aghamohammadi; Klaus Warnatz; Nima Rezaei
Journal:  J Clin Immunol       Date:  2014-05-15       Impact factor: 8.317

Review 7.  Common variable immunodeficiency.

Authors:  W Strober; K Chua
Journal:  Clin Rev Allergy Immunol       Date:  2000-10       Impact factor: 10.817

8.  ICOS-deficient and ICOS YF mutant mice fail to control Toxoplasma gondii infection of the brain.

Authors:  Carleigh A O'Brien; Tajie H Harris
Journal:  PLoS One       Date:  2020-01-24       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.